BiopTis, equine biotechnology

Who are we ?

BiopTis is a spin-off from the University of Liege (Belgium) created by two research centres: the “Centre for Oxygen Research and Development” (CORD) and the “European Equine Research Centre of Mont-le-Soie” (MLS).

BiopTis is an innovative biotechnology company, which provides to its clients and partners research and diagnostic skills and the development of new treatments in the fields of equine pathology.

The main fields covered are inflammation, oxidative stress, mitochondrial function, bone and cartilage metabolism, cell therapy, genomics and transcriptomics

How to contact us ?

BiopTis s.a.
Université de Liège, Biochimie, local 3.19 (bât B6a)
4000 Sart Tilman

Managing Director : Jacques Kuypers
Scientific Consultant : Didier Serteyn